Quantitative changes in interleukin proteins following focal stroke in the rat

Neuroscience Letters

Volumn 282, Issue 3, 2000, Pages 189-192

  Legos, Jeffrey J ^a,b   Whitmore, Robert G ^a   Erhardt, Joseph A ^a   Parsons, Andrew A ^a   Tuma, Ronald F ^b   Barone, Frank C ^a  

^a SmithKline Beecham P ^*  (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Focal cerebral ischemia; Interleukin 1; Interleukin 1 receptor antagonist; Interleukin 6; Rats

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE;

ANIMALS; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKINS; ISCHEMIC ATTACK, TRANSIENT; MALE; RATS; RATS, INBRED SHR; SIALOGLYCOPROTEINS;

EID: 0034708392     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00907-1     Document Type: Article

References (20)

1. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1993;1-78.
2. Barone F.C., Price W.J., White R.F., Willette R.N., Feuerstein G.Z. Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci. Biobehav. Rev. 16:1992;219-233.
3. Barone F.C., White R.F., Spera P.A., Ellison J., Currie R.W., Wang X., Feuerstein G.Z. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke. 29:1998;1937-1950.
4. Beamer N.B., Coull B.M., Clark W.M., Hazel J.S., Silberger J.R. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann. Neurol. 37:1995;800-805.
5. Buttini M., Sauter A., Boddeke H. Induction of interleukin-1beta mRNA after focal ischemia in the rat. Mol. Brain Res. 23:1994;126-134.
6. Clark W.M., Rinker L.G., Lessov N.S., Hazel K., Eckenstein F. Time course of IL-6 expression in experimental CNS ischemia. Neurol. Res. 21:1999;287-292.
7. Dinarello C.A. The biology of interleukin-1. Chem. Immunol. 51:1992;1-32.
8. Feuerstein G.Z., Wang X., Barone F.C. The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation. 5:1998;143-159.
9. Liu T., McDonnell P.C., Young P.R., White R.F., Siren A.L., Hallenbeck J.M., Barone F.C., Feurerstein G.Z. Interleukin-1-beta messenger RNA expression in ischemic rat cortex. Stroke. 24:1993;1746-1751.
10. Loddick S.A., Turnbull A.V., Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cerebral Blood Flow Metab. 18:1998;176-179.
11. Pantoni L., Sarti C., Inzitari D. Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives. Arterioscler. Thromb. Vasc. Biol. 18:1998;503-513.
12. Relton J.K., Martin D., Thompson R.C., Russell D.A. Peripheral administration of Interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp. Neurol. 138:1996;206-213.
13. Rothwell N.J., Relton J.K. Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage. Cerebrovasc. Brain Metab. Rev. 5:1993;178-198.
14. Tarkowski E., Rosengren L., Blomstrand C., Wikkelso C., Jensen C., Ekholm S., Tarkowski A. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke. 26:1995;1393-1398.
15. Vila N., Filella X., Deulofeu R., Ascaso C., Abellana R., Chamorro A. Cytokine-induced inflammation and long-term stroke functional outcome. J. Neurol. Sci. 162:1999;185-188.
16. Wang X.K., Barone F.C., Aiyar N.V., Feuerstein G.Z. Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke. 28:1997;155-161.
17. Wang X.K., Yue T.L., Barone F.C., White R.F., Gagnon R.C., Feuerstein G.Z. Concomitant cortical expression of TNF-αand IL-1β mRNAs follows early response gene expression in transient focal ischemia. Mol. Chem. Neuropathol. 23:1994;103-114.
18. Wang X.K., Yue T.L., Young P.R., Barone F.C., Feuerstein G.Z. Expression of interleukin-6, C-Fos, and Zif268 mRNAs in rat ischemic cortex. J. Cerebral. Blood Flow Metab. 15:1995;166-171.
19. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats [see comments]. Stroke. 26:1995;676-680. discussion 681.
20. Yang G.Y., Liu X.H., Kadoya C., Zhao Y.J., Mao Y., Davidson B.L., Betz A.L. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. J. Cerebral Blood Flow Metab. 18:1998;840-847.